07971459383

Change Language

KETHAN PHARMA DISTRIBUTORS
GST : 36ABMPO2384G1ZD

Our Products

Pharmaceutical Tablets

Pharmaceutical Injection

Pharmaceutical Capsules

Anti Cancer Injection

Mircera 50 Mcg Injection

Therapy Lotion

Cardiovascular Injection

Recombinant Tissue Plasminogen Activator For Injection 20 Mg Kit

Pharmaceutical Cream

Mouth Freshener Spray

X-Wet Saliva Supplement Mouth Spray

Oral Suspension

Megestrol Acetate Oral Suspension USP

Pharmaceutical Syrup

Curcuage Liquid

Oxaliplit 100 Oxaliplatin Injection IP

Name: Oxaliplit 100 Oxaliplatin Injection IP
Brand: KETHAN PHARMA DISTRIBUTORS
Price: 475 INR
Availability: InStock

Price 475 INR/ Unit

Get a Price/Quote

MOQ : 20 Units

Oxaliplit 100 Oxaliplatin Injection IP Specification

Indication
Used in the treatment of advanced colorectal cancer, either in combination with other medications or as directed by a physician.

Dosage Form
Injection

Salt Composition
Oxaliplatin 100 mg

Feature
Lyophilized powder for precise dosing and stability.

Ingredients
Each vial contains Oxaliplatin IP 100 mg as active ingredient.

Application

Physical Color/Texture
White to off-white, lyophilized powder.

Fermentation Smell
Odorless/Not applicable

Storage Instructions
Store below 25C, protect from light. Do not freeze.

Shelf Life
24 months from the date of manufacture.

Prescription Requirement
Prescription only (Rx).

Pack Size
Single dose vial containing 100 mg Oxaliplatin.

ATC Classification
L01XA03 - platinum-based antineoplastic agents

Intended Patient Population
Adults diagnosed with colorectal cancer.

Container Type
Type I glass vial with rubber stopper and aluminum seal.

Packaging Type
Glass vial in secondary carton pack.

Administration Route
Intravenous infusion only, after reconstitution and dilution.

USP Compliance
Formulation conforms to established pharmaceutical quality standards.

Marketed By
All Kind Healthcare

Warning
For cytotoxic use; handling and disposal as per guidelines. Use only under medical supervision.

Manufactured By
All Kind Healthcare

Hazard Category
Cytotoxic agent. Handle with care.

Reconstitution Information
Reconstitute with 20 mL of Water for Injection or as per manufacturer's guidelines.

Oxaliplit 100 Oxaliplatin Injection IP Trade Information

Minimum Order Quantity
20 Units

Payment Terms
Cash in Advance (CID)

Supply Ability
1000 Units Per Month

Delivery Time
7 Days

Main Domestic Market
All India

Oxaliplit 100 Oxaliplatin Injection IP About

Capitalise on the crowning achievement in oncology with Oxaliplit 100 Oxaliplatin Injection IP, a celebrated solution in antineoplastic therapy, in demand for advanced colorectal cancer. Each glass vial, housing 100 mg of Oxaliplatin IP as a white to off-white lyophilized powder, enables precise dosing and lasting stability. Get it now-engineered for intravenous infusion following reconstitution with Water for Injection. This towering cytotoxic agent is manufactured and marketed by All Kind Healthcare, provided with stringent USP compliance and delivered under prescription only for optimal safety and efficacy.

Oxaliplit 100: Primary Competitive Advantages and Features

Oxaliplit 100 Oxaliplatin Injection IP stands out for its celebrated lyophilized powder formulation, ensuring precision and stability throughout its 24-month shelf life. Its single-dose glass vial packaging guarantees optimal safety and integrity of the active ingredient. Designed exclusively for intravenous chemotherapy in adults with colorectal cancer, this product capitalises on its USP-compliant formulation, reinforcing its position as a reliable and in-demand choice for prescription use under medical supervision-a true crowning solution in antineoplastic therapy.

FOB Port, Supply Ability, and Certifications Information

Oxaliplit 100 Oxaliplatin Injection IP is efficiently transported from India, ensuring timely delivery through reliable transport services. Customers can estimate delivery times based on current logistics and supply chain operations. The product's supply ability is scaled to meet extensive demand, catering to both domestic and international export markets. Certified for compliance with established pharmaceutical regulations, Oxaliplit 100 guarantees quality and safety throughout the transportation and supply process, cementing its status as a dependable oncology medication.

FAQ's of Oxaliplit 100 Oxaliplatin Injection IP:

Q: How should Oxaliplit 100 Oxaliplatin Injection IP be administered?

A: It must be administered as an intravenous infusion, only after proper reconstitution and dilution by healthcare professionals and under medical supervision.

Q: What is the process for the reconstitution of Oxaliplit 100?

A: Reconstitute the lyophilized powder using 20 mL of Water for Injection or as per the manufacturer's guidelines, ensuring safe handling due to its cytotoxic nature.

Q: When should Oxaliplit 100 be used in therapy?

A: Oxaliplit 100 is indicated for use in adults diagnosed with advanced colorectal cancer, either in combination with other medications or as prescribed by a physician.

Q: Where is Oxaliplit 100 Oxaliplatin Injection manufactured and available for export?

A: It is manufactured and marketed by All Kind Healthcare in India, and is available for export, supply, and trade internationally via certified transport services.

Q: What are the primary benefits and safety features of Oxaliplit 100?

A: The injection provides precise dosing, robust stability, and stringent USP compliance. It features secure packaging in a Type I glass vial and is handled according to cytotoxic safety guidelines for optimal patient and provider safety.